Central retinal vein occlusion in a woman receiving bromocriptine.
We evaluated a unilateral retinal vascular abnormality in a 34-year-old woman receiving bromocriptine mesylate for the suppression of postpartum lactation. After using bromocriptine, 2.5 mg twice daily for 1 week, the patient complained of metamorphopsia in the left eye. A central retinal vein occlusion was found. We believe that central retinal vein occlusion in patients receiving bromocriptine, as demonstrated in our patient, is rare.
Nagaki
Y
Y
Department of Ophthalmology, Toyama Medical and Pharmaceutical University, Japan.
Hayasaka
S
S
Hiraki
S
S
Yamada
Y
Y
D000328:Adult; D001971:Bromocriptine / Q000009:adverse effects*; D018491:Dopamine Agonists / Q000009:adverse effects*; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D007774:Lactation / Q000187:drug effects; D049590:Postpartum Period; D012170:Retinal Vein Occlusion / Q000139:chemically induced* / Q000175:diagnosis
D018491:Dopamine Agonists; D001971:Bromocriptine